Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Cinoxacin

Cinoxacin: 1 brand, 2 generics; first approved Feb 28, 1992; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 2 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
2
Listed patents
0
Presentations
4

Brand (NDA) products

Originator applications
  • NDA 0180672 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGCAPSULEORALDiscontinued
    500MGCAPSULEORALDiscontinued

Generic (ANDA) products (2)

Abbreviated applications
  • CINOXACIN
    ANDA 0730051992
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    250MGCAPSULEORALDiscontinued
  • CINOXACIN
    ANDA 0730061992
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    500MGCAPSULEORALDiscontinued

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
35 yr ago
Most recent approval
35 yr ago

All 3 applications were approved in 1992.

Brand (NDA) 133%
Generic (ANDA) 267%

Cinoxacin: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.